Axillary clearance and chemotherapy rates in ER+HER2− breast cancer: secondary analysis of the SENOMAC trial

Authors

Institutions

Publication Details

Journal
The Lancet Regional Health - Europe
Published
2024-09-26
DOI
https://doi.org/10.1016/j.lanepe.2024.101083
Citations
2
Primary Topic
Breast Cancer Treatment Studies
Type
article
Field-Weighted Citation Impact
0.57

Funders

Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
article

Axillary clearance and chemotherapy rates in ER+HER2− breast cancer: secondary analysis of the SENOMAC trial

Lisa Rydén, Michalis Kontos, Roger Olofsson Bagge, Thorsten Kühn et al.
2 citations
The Lancet Regional Health - Europe
Breast Cancer Treatment Studies
0.57
article

Axillary clearance and chemotherapy rates in ER+HER2− breast cancer: secondary analysis of the SENOMAC trial

Lisa Rydén, Michalis Kontos, Roger Olofsson Bagge, Thorsten Kühn, Dan Lundstedt, Peer Christiansen, Malin Sund, Jan Frisell, Jana de Boniface, Leif Bergkvist, Tove Filtenborg Tvedskov, Sara Alkner, Robert Szulkin, Toralf Reimer, Yvette Andersson, Oreste Davide Gentilini, Birgitte Vrou Offersen
article en
2 citations

Abstract

No abstract available for this paper.
The Lancet Regional Health - EuropeVol. 47
Uppsala University (SE), University of Copenhagen (DK), Karolinska University Hospital (SE), University of Helsinki (FI), Vita-Salute San Raffaele University (IT), Lund University (SE), Universität Ulm (DE), National and Kapodistrian University of Athens (GR), Aarhus University (DK), Helsinki University Hospital (FI), Sahlgrenska University Hospital (SE), Aarhus University Hospital (DK), Gentofte Hospital (DK), Karolinska Institutet (SE), Saint Göran Hospital (SE), Västmanlands sjukhus Västerås (SE), IRCCS Ospedale San Raffaele (IT), Skåne University Hospital (SE), Centre for Cosmology and Particle Physics Phenomenology (DK), University of Rostock (DE), University of Gothenburg (SE), Umeå University (SE), Cytel (United States) (US)
Svenska Forskningsrådet Formas, Cancerfonden
Good health and well-being
Openalex Percentile: Top 31%
Breast Cancer Treatment Studies
0.57
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.